Altanova Pharma Information

AltaNova Pharma is a Swiss specialty pharmaceutical platform focused on improving access to clinically differentiated therapies for patients living with chronic and complex conditions. We are building an integrated platform spanning pharmaceutical-quality sourcing, regulatory and quality infrastructure, product commercialization, and digitally enabled patient and healthcare-professional support. Our initial focus is cannabinoid-based medicines and therapies, where patients and physicians continue to face significant challenges around product consistency, clinical differentiation, quality, education, and access. AltaNova is developing a curated portfolio of pharmaceutical-quality products supported by established international partners and a disciplined, evidence-led approach to product selection. Based in Switzerland, AltaNova is building capabilities across: * Clinically differentiated cannabinoid therapies * Pharmaceutical-quality sourcing and supply * Swiss regulatory, quality and market-access infrastructure * Physician, pharmacy and healthcare-channel development * Digital tools supporting education, access and patient navigation * Strategic partnerships with pharmaceutical and life-sciences companies AltaNova was founded by experienced pharmaceutical operators and investors with a track record of building, acquiring and scaling international specialty-pharma businesses. The team’s prior experience includes creating from concept a global respiratory pharmaceutical company that grew through more than 25 life-sciences transactions and commercial operations across international markets. Our objective is to build a trusted Swiss platform for emerging and underserved areas of medicine where rigorous pharmaceutical execution can meaningfully improve quality, consistency and patient access. Headquartered in Zug, Switzerland.